Aveanna (AVAH) 10% owner sells 1,251,909 shares at $9
Aveanna Healthcare (AVAH): insider sale reported.
Rhea-AI Filing Summary
Aveanna Healthcare (AVAH): insider sale reported. A 10% owner affiliated with J.H. Whitney disclosed sales on 10/24/2025 at $9 per share pursuant to the option to purchase additional shares in an underwritten secondary offering. J.H. Whitney VII, L.P. sold 1,251,909 shares; JHW Iliad Holdings LLC sold 224,553 shares; JHW Iliad Holdings II LLC sold 23,538 shares.
Following these transactions, reported indirect beneficial holdings included 19,292,787 shares by J.H. Whitney VII, L.P., 3,460,515 shares by JHW Iliad Holdings LLC, and 362,746 shares by JHW Iliad Holdings II LLC. Additional affiliated entities reported holdings as disclosed.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 1,500,000 shares
Net Sell
6 txns
Insider
WILLIAMS ROBERT M JR
Role
10% Owner
Sold
1,500,000 shs ($13.50M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock, $0.01 par value | 1,251,909 | $9.00 | $11.27M |
| Sale | Common Stock, $0.01 par value | 224,553 | $9.00 | $2.02M |
| Sale | Common Stock, $0.01 par value | 23,538 | $9.00 | $212K |
| holding | Common Stock, $0.01 par value | -- | -- | -- |
| holding | Common Stock, $0.01 par value | -- | -- | -- |
| holding | Common Stock, $0.01 par value | -- | -- | -- |
Holdings After Transaction:
Common Stock, $0.01 par value — 19,292,787 shares (Indirect, By J.H. Whitney VII, L.P.);
Common Stock, $0.01 par value — 3,460,515 shares (Indirect, By JHW Iliad Holdings LLC);
Common Stock, $0.01 par value — 362,746 shares (Indirect, By JHW Iliad Holdings II LLC);
Common Stock, $0.01 par value — 0 shares (Direct);
Common Stock, $0.01 par value — 15,523,809 shares (Indirect, By PSA Healthcare Investment Holdings LLC);
Common Stock, $0.01 par value — 1,426,034 shares (Indirect, By PSA Iliad Holdings LLC)
Footnotes (7)
- F1. J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of J.H. Whitney VII, L.P. ("JHW VII") and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare Investment Holdings LLC ("PSA Healthcare") and PSA Iliad Holdings LLC ("PSA Iliad Holdings"). As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to shares of common stock, $0.01 par value per share (the "Shares"), held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
- F2. Project Iliad Managing Member, LLC ("Project Iliad") is the managing member of JHW Iliad Holdings LLC ("JHW Iliad"). As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
- F3. J.H. Whitney Capital Partners, LLC ("Capital Partners") is the sole member of J.H. Whitney VII Management Co., LLC ("Management Co. VII"), which is the managing member of JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, and PSA Iliad Holdings, the "Stockholder Entities"). As a result, each of Capital Partners and Management Co. VII may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad II. Each of Capital Partners and Management Co. VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
- F4. Robert M. Williams, Jr is a Managing Member of Equity Partners VII, a Member of Project Iliad and a Senior Managing Director of Capital Partners. As a result, the undersigned may be deemed to share voting and dispositive power with respect to the Shares held by the Stockholder Entities. The undersigned disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
- F5. On October 24, 2025, J.H. Whitney VII, L.P sold 1,251,909 Shares pursuant to the option to purchase additional Shares in an underwritten secondary offering.
- F6. On October 24, 2025, JHW Iliad Holdings LLC sold 224,553 Shares pursuant to the option to purchase additional Shares in an underwritten secondary offering.
- F7. On October 24, 2025, JHW Iliad Holdings II LLC sold 23,538 Shares pursuant to the option to purchase additional Shares in an underwritten secondary offering.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider activity was reported for AVAH?
A 10% owner group reported sales on 10/24/2025 at $9 per share via the option to purchase additional shares in an underwritten secondary offering.
What did JHW Iliad Holdings LLC disclose for AVAH?
JHW Iliad Holdings LLC sold 224,553 shares at $9 per share.
What did JHW Iliad Holdings II LLC disclose for AVAH?
JHW Iliad Holdings II LLC sold 23,538 shares at $9 per share.
What are the post-transaction holdings for J.H. Whitney VII, L.P.?
Following the sales, J.H. Whitney VII, L.P. reported 19,292,787 shares as indirect beneficial ownership.
Were additional affiliated AVAH holdings disclosed?
Yes. Post-transaction amounts included 3,460,515 shares for JHW Iliad Holdings LLC and 362,746 shares for JHW Iliad Holdings II LLC.
AI-generated analysis. How Rhea-AI works. Not financial advice.
